Priya Sachdeva

Stock Analyst at UBS

(n/a)

# 4,502

Out of 4,884 analysts

4

Total ratings

n/a

Success rate

-14.22%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$320 → $330	$251.06	+31.44%	3	Apr 24, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$10.39	+63.62%	1	Jan 21, 2025

Penumbra

Apr 24, 2025

Maintains: Buy

Price Target: $320 → $330

Current: $251.06

Upside: +31.44%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $10.39

Upside: +63.62%